Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More	Frank Vinluan	01/17/20	National
Event Announcement: Xcelerating Life Sciences San Diego	Editors	01/16/20	National
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data	Frank Vinluan	01/14/20	National
Daré Bioscience Inks Deal With Bayer for Non-Hormonal Contraceptive	Sarah de Crescenzo	01/14/20	San Diego
NeoGenomics Nabs Human Longevity’s Oncology Division for $37M	Melissa Fassbender	01/13/20	National
Neurocrine, in Second Epilepsy Deal, Pairs With Swiss Biotech Idorsia	Sarah de Crescenzo	01/11/20	San Diego
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More	Sarah de Crescenzo	01/10/20	National
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs	Sarah de Crescenzo	01/09/20	San Diego
Empirico Raises $17M, Inks 3-Year Antisense Collaboration with Ionis	Sarah de Crescenzo	01/09/20	San Diego
Mirati Adds Execs With Commercial Experience at Spark, Bristol-Myers	Sarah de Crescenzo	01/08/20	San Diego
Celgene-Seeded PharmAkea Sells Last Fibrotic Drug Candidate to Galecto	Sarah de Crescenzo	01/07/20	San Diego
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic	Sarah de Crescenzo	01/07/20	San Diego
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More	Frank Vinluan	01/03/20	National
After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger	Sarah de Crescenzo	01/03/20	San Diego
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More	Sarah de Crescenzo	12/20/19	National
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights	Sarah de Crescenzo	12/19/19	San Diego
FTC Challenges PacBio Acquisition, Says Illumina is a “Monopolist”	Sarah de Crescenzo	12/18/19	San Diego
Orbiting Organoids: Research in Space to Unveil New Neurodegeneration Insight	Melissa Fassbender	12/18/19	National
Organovo’s Demise Offers Path for Tarveda to Join the Public Markets	Sarah de Crescenzo	12/16/19	San Diego
Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More	Frank Vinluan	12/13/19	National
Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy	Sarah de Crescenzo	12/12/19	San Diego
Zentalis Steps Out With $147M Raised to Develop “Tried and True” Small Molecules	Melissa Fassbender	12/10/19	National
Scripps Research, AbbVie Expand Drug Discovery Deal Beyond Cancer	Sarah de Crescenzo	12/10/19	San Diego
Eying Cancer Combos, Sanofi to Splash Out $2.5B on San Diego’s Synthorx	Sarah de Crescenzo	12/09/19	San Diego
Insitro Hires Serafim Batzoglou As Its First Chief Data Officer	Melissa Fassbender	12/09/19	San Diego
3 Takeaways From the Resurrection of Biogen’s Alzheimer’s Drug	Sarah de Crescenzo	12/06/19	San Diego
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis	Sarah de Crescenzo	12/06/19	San Diego
Bio Roundup: Biogen at CTAD, Sage’s Stumble, Astellas’s $3B Offer & More	Sarah de Crescenzo	12/06/19	National
Biogen Points to Enrollment and Dosing to Explain Alzheimer’s Results	Sarah de Crescenzo	12/05/19	National
As Alzheimer’s Conference Kicks Off, All Eyes Are on Biogen’s Drug	Sarah de Crescenzo	12/05/19	San Diego
Page 1 of 339	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders

Sponsored · Whitepaper
Accelerating Life Sciences Product Development & Commercialization
Best practices to drive digital adoption in life sciences
DocuSign

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems